Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Type1 Diabetes Mellitus or Autoimmune Diabetes
and you are
over 18
years old
This is a medium phase trial determining
the safety and dosage of the new treatment, as well as its efficacy.
Show me locations

The purpose

The purpose of this study is to investigate the safety and therapeutic effect of ex-vivo expanded umbilical cord blood regulatory T cells adjunct with Liraglutide on autoimmune diabetes.

Provided treatments

  • Drug: Liraglutide
  • Biological: UCB-Treg
  • Drug: Insulin
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03011021. The sponsor of the trial is Second Xiangya hospital of Central South University and it is looking for 40 volunteers for the current phase.
Official trial title:
Phase 1/ Phase 2 Study of the Therapeutic Effect of Ex-vivo Expanded Umbilical Cord Blood Regulatory T Cells With Liraglutide on Autoimmune Diabetes